JOSÉ LUIS BALIBREA CANTERO-rekin lankidetzan egindako argitalpenak (21)

2007

  1. Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer

    Oncology Reports, Vol. 17, Núm. 1, pp. 217-223

  2. Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma

    Hepato-Gastroenterology, Vol. 54, Núm. 73, pp. 315-319

2006

  1. Correlations of telomere length, telomerase activity, and telomerlc-repeat binding factor 1 expression in colorectal carcinoma: Prognostic indications

    Cancer, Vol. 106, Núm. 3, pp. 541-551

2005

  1. Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer

    Oncology Reports, Vol. 13, Núm. 1, pp. 115-120

2004

  1. Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: clinical implications.

    International journal of oncology, Vol. 24, Núm. 2, pp. 349-355

  2. Relationship between 3p deletions and telomerase activity in non-small-cell lung cancer: Prognostic implications

    British Journal of Cancer, Vol. 90, Núm. 10, pp. 1983-1988

2002

  1. Cooperative role of telomerase activity and p16 expression in the prognosis of non-small-cell lung cancer

    Journal of Clinical Oncology, Vol. 20, Núm. 1, pp. 254-262

  2. Genomic organization of a novel glycosylphosphatidylinositol MAM gene expressed in human tissues and tumors

    Oncogene, Vol. 21, Núm. 19, pp. 3089-3094

  3. Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors

    Cancer Research, Vol. 62, Núm. 13, pp. 3855-3860

2000

  1. Detection of telomerase activity in human carcinomas using a trap-ELISA method: correlation with hTR and hTERT expression.

    International journal of oncology, Vol. 16, Núm. 3, pp. 623-628

  2. Loss of heterozygosity at 3p23 is correlated with poor survival in patients with colorectal carcinoma

    Cancer, Vol. 89, Núm. 6, pp. 1220-1227

1999

  1. DNA amplification on chromosome 6p12 in non small cell lung cancer detected by arbitrarily primed polymerase chain reaction

    International Journal of Cancer, Vol. 84, Núm. 4, pp. 344-349

  2. Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer

    European Journal of Cancer, Vol. 35, Núm. 12, pp. 1676-1682

1998

  1. Comparative survival analysis of p53 gene mutations and protein accumulation in colorectal cancer

    Oncology, Vol. 55, Núm. 3, pp. 249-257

  2. Genetic abnormalities and microsatellite instability in colorectal cancer

    Cancer Detection and Prevention, Vol. 22, Núm. 5, pp. 383-395

  3. Prognostic significance of p53 gene mutations in squamous cell carcinoma of the lung

    Oncology Reports, Vol. 5, Núm. 5, pp. 1129-1133

  4. Prognostic value of genomic damage in non-small-cell lung cancer

    British Journal of Cancer, Vol. 77, Núm. 11, pp. 1971-1977

  5. p53 Exon 7 mutations as a predictor of poor prognosis in patients with colorectal cancer

    Cancer Letters, Vol. 130, Núm. 1-2, pp. 153-160

1997

  1. p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer

    British Journal of Cancer, Vol. 76, Núm. 1, pp. 44-51

1996

  1. Association of K-ras codon 12 transversions with short survival in non-small cell lung cancer

    International Journal of Oncology, Vol. 9, Núm. 6, pp. 1307-1311